Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEco Animal Regulatory News (EAH)

Share Price Information for Eco Animal (EAH)

Share Price is delayed by 15 minutes
Get Live Data
91.00    3.00 (3.41%)
Bid:
90.00
Ask:
92.00
Spread: 2.00 (2.222%)
Market Cap: £61.05m
EAH Live PriceLast checked at - London Stock Exchange

Intraday Eco Animal Share Chart

Holding(s) in Company

31 Oct 2014 09:18

For filings with the FCA include the annex
For filings with issuer exclude the annex
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi
1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii Eco Animal Health Group plc
2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights

X

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments
An event changing the breakdown of voting rights
Other (please specify):
3. Full name of person(s) subject to thenotification obligation: iii Schroders plc
4. Full name of shareholder(s)(if different from 3.):iv
5. Date of the transaction and date onwhich the threshold is crossed orreached: v 28.10.14
6. Date on which issuer notified: 30.10.14
7. Threshold(s) that is/are crossed orreached: vi, vii 18% - 17%
8. Notified details:
A: Voting rights attached to shares viii, ix
Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction Resulting situation after the triggering transaction
NumberofShares NumberofVotingRights Numberof shares Number of votingrights % of voting rights x
Direct xi Indirect xii Direct Indirect
Ordinary

GB0032036807

13,046,826 11,428,010 12,631,973 N/A 11,023,807 N/A 17.645%
B: Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financialinstrument Expirationdate xiii Exercise/ Conversion Period xiv Number of votingrights that may beacquired if theinstrument isexercised/ converted. % of votingrights
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi
Resulting situation after the triggering transaction
Type of financialinstrument Exercise price Expiration date xvii Exercise/Conversion period xviii Number of voting rights instrument refers to % of voting rights xix, xx

Nominal Delta
Total (A+B+C)
Number of voting rights Percentage of voting rights
11,023,807 17.645%
9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

Schroder Investment Management Limited 10,975,130 17.580%

Schroder & Co. Limited 48,677 0.078%

Proxy Voting:
10. Name of the proxy holder:
11. Number of voting rights proxy holder will ceaseto hold:
12. Date on which proxy holder will cease to holdvoting rights:
13. Additional information: The shares referred to in section 9 are held in portfolios managed by those firms on a discretionary basis for clients under investment management agreements. This disclosure has been calculated based on issue share capital amount 62,460,931.
14. Contact name: Scott Dickenson
15. Contact telephone number: 020 7658 6000

Copyright Business Wire 2014

Date   Source Headline
30th Apr 20212:00 pmRNSBlock listing Interim Review
30th Apr 20212:00 pmRNSTotal Voting Rights
29th Apr 20217:00 amRNSDirector/PDMR Shareholding
21st Apr 20214:33 pmRNSDirector/PDMR Shareholding
8th Mar 20217:00 amRNSTrading Update
4th Mar 20213:07 pmRNSResult of AGM & GM
25th Feb 202111:15 amRNSClarification of new long term incentive plan
18th Feb 20211:59 pmRNSHolding(s) in Company
4th Feb 20217:30 amRNSRestoration - Eco Animal Health Group plc
4th Feb 20217:10 amRNSAnnual & Interim Reports Publication & AGM Notice
4th Feb 20217:02 amRNSHalf-Year Report
4th Feb 20217:00 amRNSFinal Results for Year Ended 31 March 2020
21st Jan 20217:00 amRNSTrading Update
13th Jan 20217:00 amRNSAIVLOSIN® USA & CANADIAN MARKETING AUTHORISATIONS
7th Jan 20217:00 amRNSSwine Vaccine Brazilian Marketing Authorisation
4th Jan 20217:30 amRNSSuspension - Eco Animal Health Group Plc
23rd Dec 202011:50 amRNSHolding(s) in Company
21st Dec 20207:00 amRNSResults for year ended 31 March 2020 delayed
24th Nov 20204:34 pmRNSNotice of Results for Year Ended 31 March 2020
22nd Oct 20205:57 pmRNSHolding(s) in Company
21st Oct 20207:00 amRNSTrading Update
15th Oct 20207:00 amRNSLicensing Deals
6th Oct 20206:19 pmRNSHolding(s) in Company
6th Oct 202012:42 pmRNSHolding(s) in Company
11th Sep 202011:08 amRNSNOTICE OF RESULTS FOR YEAR ENDED 31 MARCH 2020
23rd Jul 202010:14 amRNSHolding(s) in Company
14th Jul 20205:30 pmRNSHolding(s) in Company
29th Jun 20207:00 amRNSEUROPEAN MARKETING AUTHORISATION FOR AIVLOSIN®
18th Jun 20205:24 pmRNSHolding(s) in Company
12th Jun 202011:24 amRNSHolding(s) in Company
11th Jun 20205:01 pmRNSHolding(s) in Company
10th Jun 20204:36 pmRNSPrice Monitoring Extension
10th Jun 20207:00 amRNSTrading Update
22nd May 20207:00 amRNSEuropean Marketing Authorisation Opinion
27th Apr 20207:00 amRNSBoard Appointment
24th Apr 20204:04 pmRNSHolding(s) in Company
9th Mar 20205:44 pmRNSHolding(s) in Company
20th Feb 20207:00 amRNSHolding(s) in Company
20th Feb 20207:00 amRNSHolding(s) in Company
3rd Feb 20207:00 amRNSBlock listing Interim Return
3rd Feb 20207:00 amRNSTotal Voting Rights
30th Jan 20207:00 amRNSMarket Authorisation in Indonesia
31st Dec 20197:00 amRNSHalf-year Report
26th Nov 20199:13 amBUSHolding(s) in Company
21st Nov 20193:25 pmBUSHolding(s) in Company
13th Nov 20199:16 amBUSHolding(s) in Company
13th Nov 20198:53 amBUSHolding(s) in Company
12th Nov 20193:16 pmBUSHolding(s) in Company
12th Nov 20193:14 pmBUSHolding(s) in Company
11th Nov 20197:00 amBUSTrading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.